Preclinical Evaluation of Zn(II) Self-Assemblies with Selective Cytotoxic Activity Against Cancer Cells In Vitro and In Ovo. (2024)
Attributed to:
Self-Assembled Cryptate Kinase Inhibitors as Anti-Cancer Therapeutic Agents.
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/chem.202302803
PubMed Identifier: 37874745
Publication URI: http://europepmc.org/abstract/MED/37874745
Type: Journal Article/Review
Volume: 30
Parent Publication: Chemistry (Weinheim an der Bergstrasse, Germany)
Issue: 3
ISSN: 0947-6539